Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4217133
Max Phase: Preclinical
Molecular Formula: C36H46Cl2N6O6S
Molecular Weight: 761.77
Molecule Type: Small molecule
Associated Items:
ID: ALA4217133
Max Phase: Preclinical
Molecular Formula: C36H46Cl2N6O6S
Molecular Weight: 761.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)CCCCc1cc(Cl)c(CN2CSC[C@H]2C(=O)N2CCN(C3CC3)c3ccccc32)cc1Cl)C(=O)O
Standard InChI: InChI=1S/C36H46Cl2N6O6S/c1-21(33(46)40-22(2)34(47)41-23(3)36(49)50)39-32(45)11-7-4-8-24-16-28(38)25(17-27(24)37)18-42-20-51-19-31(42)35(48)44-15-14-43(26-12-13-26)29-9-5-6-10-30(29)44/h5-6,9-10,16-17,21-23,26,31H,4,7-8,11-15,18-20H2,1-3H3,(H,39,45)(H,40,46)(H,41,47)(H,49,50)/t21-,22-,23-,31+/m1/s1
Standard InChI Key: NXFCVZUVDCJRNI-BVISUOFCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 761.77 | Molecular Weight (Monoisotopic): 760.2577 | AlogP: 4.20 | #Rotatable Bonds: 15 |
Polar Surface Area: 151.39 | Molecular Species: ACID | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.86 | CX Basic pKa: 3.44 | CX LogP: 3.60 | CX LogD: 0.91 |
Aromatic Rings: 2 | Heavy Atoms: 51 | QED Weighted: 0.20 | Np Likeness Score: -0.68 |
1. Chen T, Reich NW, Bell N, Finn PD, Rodriguez D, Kohler J, Kozuka K, He L, Spencer AG, Charmot D, Navre M, Carreras CW, Koo-McCoy S, Tabora J, Caldwell JS, Jacobs JW, Lewis JG.. (2018) Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5)., 61 (17): [PMID:30141927] [10.1021/acs.jmedchem.8b00308] |
Source(1):